Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CLONAZEPAM

CLONAZEPAM

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLONAZEPAM is listed in Drugs@FDA under application 211033 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLONAZEPAM Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 2MG Sponsor ALEMBIC Submission history Latest submission status date: 2023-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLONAZEPAM is listed in Drugs@FDA under application 211033 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLONAZEPAM Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 2MG Sponsor ALEMBIC Submission history Latest submission status date: 2023-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.